register

News & Trends - MedTech & Diagnostics

Stryker partners with local researchers to advance shoulder joint surgery

Health Industry Hub | May 3, 2024 |

MedTech & Diagnostics News: Joint replacement is a commonly performed major surgical procedure that has considerable success in alleviating pain and disability. Aimed at improving shoulder joint surgery and reducing surgical revision rates, Dr Maxence Lavaill from QUT School of Mechanical, Medical and Process Engineering has been awarded an Advance Queensland Industry Research Fellowship of $160,000 with industry partner Stryker.

At least 2000 total shoulder replacements were conducted in Queensland alone last year. Dr Lavaill (above) will focus on developing a novel in-silico musculoskeletal simulation tool for shoulder joint surgery.

“Shoulder implant surgery records the largest failure rate amongst all human joints – 15% of patients have to return to theatre after failure of their shoulder implant, whereas hip joint replacement revisions are at five per cent,” Dr Lavaill said.

“This revision rate causes negative effects on patients’ health and high social and economic impacts. Shoulder function is driven largely by joint forces exerted through muscle contractions. As current surgical planning accounts only for bone with no consideration of muscles, implementing and predicting muscle actions in the surgery planning process has the potential to improve these high shoulder implant failure rates,” he explained.

Dr Lavaill’s project aims to reduce revision rates by developing an automated, holistic approach to shoulder surgery planning which involves the patient’s specific muscle function as well as their bone structure.

“Central to this approach is the development of cutting-edge, musculoskeletal models validated using instrumented-implant data from patients who have undergone shoulder implant surgery,” he said. “This will allow us to robustly test implant designs and evaluate their performance in restoring patient function.”

The collaboration between Stryker and ARC Training Centre for Joint Biomechanics will allow for the developed models to assist the company in producing the next generation of surgical planning software on a sound and evidence-based simulation-driven design for shoulders.

“This will ultimately enhance the implant’s performance and longevity as well as improve patients’ quality of life,” Dr Lavaill said.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Edwards Lifesciences VP challenges us to 'dream bigger' for underserved communities

Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities

Health Industry Hub | November 11, 2024 |

Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]

More


News & Trends - MedTech & Diagnostics

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Health Industry Hub | November 11, 2024 |

Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]

More


News & Trends - MedTech & Diagnostics

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Health Industry Hub | November 11, 2024 |

Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]

More


News & Trends - Pharmaceuticals

Australia’s first Cholesterol Awareness Week launched to tackle nation’s 'silent disease'

Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’

Health Industry Hub | November 11, 2024 |

Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]

More


This content is copyright protected. Please subscribe to gain access.